147
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Organizational Issues in the Implementation of a Hospital-Based Syringe Exchange Program

, , , , &
Pages 901-915 | Published online: 23 Apr 2010

References

  • Bluthenthal, R. N., Kral, A. H., Lorvick, J., Watters, J. K. (1997). Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Medical Anthropology, 18:61–83.
  • Brown, L., Masson, C. L., Sorensen, J. L., Perlman, D. C., Delucchi, K., Sporer, K., et al. (2003). Evaluation of a hospital-based syringe exchange: preliminary results. Drug and Alcohol Dependence, 70.
  • Burris, S., Lurie, P., Abrahamson, D., Rich, J. (2000). Physician prescribing of sterile injection equipment to prevent HIV infection: time for action. Annals of Internal Medicine, 133:218–226.
  • Burris, S., Vernick, J. S., Ditzler, A., Strathdee, S. (2002). The legality of selling or giving syringes to injection drug users. Journal of the American Pharmaceutical Association, 42:S13–S18.
  • Centers for Disease Control. (2004). HIV/AIDS survelliance report: cases of HIV infection and AIDS in the United States, 2004. Atlanta.
  • Centers for Disease Control & Prevention. (1999). CDC gives communities prevention strategies. AIDS Alert, 14:66.
  • Centers for Disease Control & Prevention. (2000). A comprehensive approach: preventing blood-borne infections among injection drug users. Retrieved December 8, 2009, from www.cdc.gov/idu/pubs/ca/intro.htm
  • Collins, C., Summers, T. (2002). Syringe exchange and AB 136: the dynamics of local consideration in six California communities Retrieved December 8, 2009, from www.kff.org/hivaids/6018-index.cfm
  • Commonwealth Department of Health and Ageing. (2002). Return on investment in needle and syringe programs in Australia. 1–145.
  • Deren, S., Stephens, R., Davis, W. R., Feucht, T. E., Tortu, S. (1994). The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Reports, 109;548–554.
  • Des Jarlais, D. C., Fisher, D., Clark, J., Trubatch, B., Milliken, J., Yancovitz, M., et al. (2001). Providing HBV vaccination to injecting drug users: referral to health care clinics and on-site at a syringe exchange program. American Journal of Public Health, 91:1791–1792.
  • Des Jarlais, D. C., Friedman, S. R. (1998). Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports, 113:182–188.
  • Doherty, M. C., Garfein, R. S., Vlahov, D. (1997). Discarded needles do not increase soon after the opening of a needle exchange program. American Journal of Epidemiology, 145;730–737.
  • Downing, M., Riess, T. H., Vernon, K., Mulia, N., Hollingquest, M., McKnight, C., et al. (2005). What's community got to do with it? Implementation models of syringe exchange programs. AIDS Education and Prevention, 17(1):68–78.
  • Faden, R., Beauchamp, T. (1986). A history and theory of informed consent. New York: Oxford University Press.
  • Friedman, S. R., Lieb, S., Tempalski, B., Cooper, H., Keem, M., Friedman, R., et al. (2005). HIV among injection drug users in large US metropolitan areas, 1998. Journal of Urban Health, 82:434–445.
  • Friedman, S. R., Tempalski, B., Cooper, H., Perlis, T., Keem, M., Friedman, R., et al. (2004). Estimating numbers of injecting drug users in metropolitan areas for stuctural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. Journal of Urban Health, 81:377–400.
  • Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., Nelson, K. E. (1996). Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86:655–661.
  • Guydish, J., Bucardo, J., Young, M., Woods, W., Grinstead, O., Clark, W. (1993). Evaluating needle exchange: are there negative effects? AIDS, 7:871–876.
  • Hankins, C. A. (1998). Syringe exchange in Canada: good but not enough to stem the HIV tide. Substance Use and Misuse, 33:1129–1146.
  • Hartgers, C., Buning, E. C., van Santen, G. W., Verster, A. D., Coutinho, R. A. (1989). The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS, 3:571–576.
  • Henman, A. R., Paone, D., Des Jarlais, D. C., Kochems, L. M., Friedman, S. R. (1998). Injection drug users as social actors: a stigmatized community's participation in the syringe exchange programmes of New York City. AIDS Care, 10;397–408.
  • Holmberg, S. (1996). The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. American Journal of Public Health, 86:642–654.
  • Hudoba, M., Grenyer, B., O’Toole, M. (2004). Development of an enhanced needle and syringe programme: the First Step programme pilot. Drug and Alcohol Review, 23;295–297.
  • Joseph, H., Stancliff, S., Langrod, J. (2000). Methadone maintenance treatment (MMT): a review of historical and clinical issues. the Mount Sinai Journal of Medicine, 67:347–364.
  • Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., et al. (2005). High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health, 27;62–66.
  • Khoshnood, K., Blankenship, K. M., Pollack, H. A., Roan, C. T., Altice, F. L. (2000). Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS and Public Policy Journal, 15;88–94.
  • Kral, A. H., Anderson, R., Flynn, N. M., Bluthenthal, R. N. (2004). Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Epidemiology and Social Science, 37:1307–1312.
  • Mark, T., Woody, G., Juday, T., Kleber, H. (2001). The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence, 61:195–206.
  • Marx, M. A., Crape, B., Brookmeyer, R. S., Junge, B., Latkin, C., Vlahov, D., et al. (2000). Trends in crime and the introduction of a needle exchange program. American Journal of Public Health, 90:1933–1936.
  • Masson, C. L., Sorensen, J. L., Batki, S. L., Okin, R. L., Delucchi, K. L., Perlman, D. C. (2002). Medical service use and financial charges among opioid users at a public hospital. Drug and Alcohol Dependence, 66:45–50.
  • Miller, R. L. (2001). Innovation in HIV prevention: organizational and intervention characteristics affecting program adoption. American Journal of Community Psychology, 29;621–647.
  • Murrill, C. S., Weeks, H., Castrucci, B. C., Weinstock, H. S., Bell, B. P., Spruill, C., et al. (2002). Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 U.S. cities. American Journal of Public Health, 92:385–387.
  • Parsons, J., Hickman, M., Turnbull, P. J., McSweeney, T., Stimson, G. V., Judd, A., et al. (2002). Over a decade of syringe exchange: results from 1997 UK survey. Addiction, 97:845–850.
  • Perlman, D. C., Freidmann, P., Horn, L., Nugent, A., Schoeb, V., Carey, J., et al. (2003). Impact of monetray incentives on adherence to referral for screening chest x-rays after syringe exchange based tuberculin skin testing. Journal of Urban Health, 80:428–437.
  • Rockwell, R., Des Jarlais, D. C., Friedman, S. R., Perlis, T. E., Paone, D. (1999). Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care, 11;437–442.
  • Tempalski, B. (2006). Placing the dynamics of syringe exchange programs in the United States. Health and Place, 13(2):417–431.
  • Tishler, C. L., Bartholomae, S. (2002). The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. Journal of Clinical Pharmacology, 42:365–373.
  • Wodak, A., Cooney, A. (2006). Do needle exchange programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Substance Use and Misuse, 41:777–813.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.